Member Info for alfista

Yes, I think it may be early subscribers, or IF recognising shareholders. Either way, I'll take it.

Yes, of course it is Bern, but it has resulted in a big change of leverage rather than being frittered away.

Full credit to the management, Very impressive turn around in financial performance, especially dumping so much debt.

Well I hope he makes a much bigger gain than that.

But then I would, wouldn't I.

Looks like .70 is the price now.

Decent buy, but we need new blood on the buying side IMHO

The ideal start point to negotiate anything would be after the significant rise in revenues. A start point at this level doesn't give Ian sufficient leverage IMHO. Just one multiple of sales to current brands would make quite a difference in outlook, becoming self funding would be really good. The size of the next stock order still gives cause for concern regarding funding, but it's not necessarily going to result in a placing.

Chinese new year about to begin, so very unlikely we'll see anything announced in the short term.

Sodoi

Unlikely.

This year Rodders much more likely.

A very small turnover increase, even without China.

Application of Fruitflow to various medical issues is still at early stages, more than possible that more could be announced. The vital importance of smooth bloodflow to almost every aspect of human health is quite obvious.

Mutleys is alive folks?

he's been sitting at his desk near the loos for years, just waiting for an instruction to launch a new campaign.

It's a job I guess.

ByHealth are a small outfit? Y'right.

Only spent a couple of million? Total BS

Going nowhere with Fruitflow? That'll be why DSM have opened up an entire new application for Fruitflow, including the possibility of it being defined as a drug for the first time.

Undeniably it has taken a long time, but then nobody knew how long it would take.

The allusion to the prospect of a "Change of Control" is brand new though, as is the mention of relations at a "high level" with ByHealth.

If an investor has an average of 10p (Colby) they will be disappointed.

If they are at well below a penny, then it's a different story

IMHO

Really?

I thought it was rpg7

Are Dr Asim and Dr Niamh not also on the BoD ?

Mr Lucas doesn't have a large enough holding, nobody does. To gain "control" they would first have to acquire such a holding, and this means they would have to buy them from other holders who have waited a long time for a good return.

Aint gonna happen IMHO

We are all trying to assess the meaning behind the new words that have been introduced in the last update and this share option award.

Projecting the IP forward, we have the potential of a giant market in Chinaalso the prospect of Fruitflow as a drug, and the whole new field of gut health products to come.

Would all of that be worth 2p a share?

If the result of a sale of the whole of the company gave Ian Ford a hefty final pay day, and then retirement, I would think that gives him a strong incentive to achieve the best deal possible. A reward for persistence in the face of many challenges. Personally, 2p would mildly disappoint me

That would be a major shareholder who operated on motives other than petty jealousy I guess.

If it means that Ian Ford has negotiated a favourable deal with a buyer, and the last update did state that there had been contact at the highest level with BH, then I consider this award as more than appropriate. To make deals happen has always required the right sort of people, and always commands a price tag. So long as the deal is a clean one at a good premium to today's rate, it aint a problem for me.

Been some time since we had a snidey basher. Words are so familiar, how many previous ID's have you used? Or have you lost count?

Increasing sales, that's what we were looking for, and that's what we can see, and none of that increase is ByHealth related, so your feeble bashing of them is deeply unimpressive. The period of full control of sales by Provexis is very short indeed, but they have increased both the number of active brands, and the volume of sales to those brands. project that forwards and it's obvious that the line will be crossed. If Blue Cap is achieved, then we'll all have a new growth metric to decipher.

Well done. David's influence restoring prospects,

Big difference between hapless and evil.

IMVHO

All conjecture, but just another point if I may.

Invoice financing, or factoring, usually costs around 5% if the invoice is to a blue chip company, perhaps less is also covered by an export guarantee scheme. If the invoice is a substantial one, it would be devastatingly easy to present a lender with a profit forecast, so easy I could do it in about ten minutes, having done so on many occasions over the years. Ian Ford has far more ability in that area.

If it is a call on shareholders, it should be the last unless the business moves up to a very high level. An offer to all holders would be my preference, easy to see that it could be over subscribed given the news flow that would be attached to it

Just a point re: your funding comment Bern. If PXS is in possession of a firm contract for large and ongoing quantities, the there are several funding options other than shareholders available. I'm not sure of there are still export guarantee schemes in place, who could know with the clown show Guvv'ment we have.

Agreed.

I believe it's safe to assume that the company knows what size a ByHealth order would be. The knowledge that the speed of production of future orders is being mentioned for the first time is significant. Feeding products which are likely to be heavily promoted within China means that the supply chain has to be capable of rapid escalation. This itself carries some risk. However, assuming that a new level of turnover would create the possibility of heavier promotion in other markets, thereby spreading the supply acceleration in other markets, there will be substantial head scratching occurring at this time IMHO.

Some of this is reading between the lines to some extent, but those couple of language changes point in that direction.